Notice of Intent to Sole Source – PREVENTIONGENETICS LLC – laboratory genetic testing services

Closed Pre-Solicitation Posted

Solicitation number
NOI-OD-26-008338
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
621511 Medical Laboratories
Place of performance
Bethesda, Maryland 20892, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health Clinical Center intends to sole-source a one-year base period plus four one-year option periods of laboratory genetic testing services to Prevention Genetics LLC, with a comment submission deadline of August 13, 2026. This procurement is not open to competition.

Prevention Genetics has been identified as the only responsible source capable of providing the required combination of CLIA-certified testing, TNXB gene analysis, CAH-X characterization, comprehensive Ehlers-Danlos Syndrome genetic testing, and historical sample continuity. The Government determined that no other source can meet these technical requirements without substantial duplication of cost, disruption to ongoing research activities, or unacceptable risk to long-term clinical research data integrity. The contractor's proprietary historical testing database, retained patient samples, and established testing methodology create barriers to competition that cannot be overcome without compromising the continuity and validity of ongoing research efforts.

This acquisition is conducted under FAR Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), which permits sole-source awards for purchases not exceeding the Simplified Acquisition Threshold when only one source is reasonably available. The contract is exempt from FAR Part 6 competition requirements. NAICS code 621511 (Medical Laboratories); PSC Q301 (Reference Laboratory Testing). Comments should reference posting number NOI-OD-26-008338 and be directed to Ryssa Nix, Contract Specialist, at Ryssa.nix@nih.gov.

Notice text

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.

This procurement is for a one-year base period and four one-year option periods of laboratory genetic testing services with PREVENTIONGENETICS LLC. Based on the department's review of available testing capabilities and the unique technical requirements of the protocol, no other source has been identified that can provide the combination of CLIA-certified testing, historical sample continuity, TNXB gene analysis, CAH-X characterization, and comprehensive EDS genetic testing required to meet the Government's needs. Consequently, Prevention Genetics is the only responsible source capable of providing the required services without substantial duplication of cost, disruption to ongoing research activities, and unacceptable risk to the integrity of long-term clinical research data. Due to the proprietary nature of the contractor's historical testing database, retained patient samples, and established testing methodology used throughout the study, the Government is unable to overcome the barriers to competition without incurring substantial duplication of cost and compromising the continuity and validity of ongoing research efforts.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.

Notice Type: Notice of Intent

NAICS Code: 621511

PSC Code: Q301

Posted Date: 07/30/2026

Close Date: 08/13/2026 12pm EST

End User IC: Clinical Center

POC Name: Ryssa Nix

Email Address: Ryssa.nix@nih.gov

Files

File Type Posted
NOI to sole source under SAT.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
RNA sequencing and whole genome sequencing services Bethesda, Maryland 20892, United States · NAICS 32599 Office of Logisitics and Acquisition Operations No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Preventative Maintenance and FullCare Service Support for Cytiva Sepax C-PRO Cell Separation Systems Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity